Mollinedo Faustino, Gajate Consuelo
Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain; Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, E-37007 Salamanca, Spain.
Adv Biol Regul. 2015 Jan;57:130-46. doi: 10.1016/j.jbior.2014.10.003. Epub 2014 Oct 27.
Cell signaling does not apparently occur randomly over the cell surface, but it seems to be integrated very often into cholesterol-rich membrane domains, termed lipid rafts. Membrane lipid rafts are highly ordered membrane domains that are enriched in cholesterol, sphingolipids and gangliosides, and behave as major modulators of membrane geometry, lateral movement of molecules, traffic and signal transduction. Because the lipid and protein composition of membrane rafts differs from that of the surrounding membrane, they provide an additional level of compartmentalization, serving as sorting platforms and hubs for signal transduction proteins. A wide number of signal transduction processes related to cell adhesion, migration, as well as to cell survival and proliferation, which play major roles in cancer development and progression, are dependent on lipid rafts. Despite lipid rafts harbor mainly critical survival signaling pathways, including insulin-like growth factor I (IGF-I)/phosphatidylinositol 3-kinase (PI3K)/Akt signaling, recent evidence suggests that these membrane domains can also house death receptor-mediated apoptotic signaling. Recruitment of this death receptor signaling pathway in membrane rafts can be pharmacologically modulated, thus opening up the possibility to regulate cell demise with a therapeutic use. The synthetic ether phospholipid edelfosine shows a high affinity for cholesterol and accumulates in lipid rafts in a number of malignant hematological cells, leading to an efficient in vitro and in vivo antitumor activity by inducing translocation of death receptors and downstream signaling molecules to these membrane domains. Additional antitumor drugs have also been shown to act, at least in part, by recruiting death receptors in lipid rafts. The partition of death receptors together with downstream apoptotic signaling molecules in membrane rafts has led us to postulate the concept of a special liquid-ordered membrane platform coined as "cluster of apoptotic signaling molecule-enriched rafts" (CASMER), referring to raft platforms enriched in apoptotic molecules. CASMERs act as scaffolds for apoptosis signaling compartmentalization, facilitating and stabilizing protein-protein interactions by local assembly of cross-interacting molecules, which leads to apoptosis amplification and a decrease in apoptotic signal threshold. Edelfosine also displaced survival PI3K/Akt signaling from lipid rafts, leading to Akt inhibition, in mantle cell lymphoma cells. Thus, membrane rafts could act as scaffold structures where segregation of pro- from anti-apoptotic molecules could take place. In this review, we summarize our view of how reorganization of the protein composition of lipid raft membrane domains regulates cell death and therefore it might be envisaged as a novel target in the treatment of cancer.
细胞信号传导显然并非随机发生在细胞表面,而是似乎常常整合到富含胆固醇的膜结构域中,即所谓的脂筏。膜脂筏是高度有序的膜结构域,富含胆固醇、鞘脂和神经节苷脂,并且作为膜几何形状、分子侧向运动、运输和信号转导的主要调节因子。由于膜脂筏的脂质和蛋白质组成与周围膜不同,它们提供了额外的分隔层次,充当信号转导蛋白的分选平台和枢纽。许多与细胞黏附、迁移以及细胞存活和增殖相关的信号转导过程在癌症发生和发展中起主要作用,这些过程依赖于脂筏。尽管脂筏主要包含关键的存活信号通路,包括胰岛素样生长因子I(IGF-I)/磷脂酰肌醇3激酶(PI3K)/Akt信号通路,但最近的证据表明,这些膜结构域也可以容纳死亡受体介导的凋亡信号。膜脂筏中这种死亡受体信号通路的募集可以通过药理学方法进行调节,从而为通过治疗用途调节细胞死亡开辟了可能性。合成醚磷脂依地福新对胆固醇具有高亲和力,并在许多恶性血液学细胞的脂筏中积累,通过诱导死亡受体和下游信号分子向这些膜结构域的易位,产生高效的体外和体内抗肿瘤活性。其他抗肿瘤药物也已被证明至少部分通过募集脂筏中的死亡受体发挥作用。死亡受体与下游凋亡信号分子在膜脂筏中的分隔促使我们提出一个特殊的液晶有序膜平台的概念,即“富含凋亡信号分子的脂筏簇”(CASMER),指富含凋亡分子的脂筏平台。CASMER作为凋亡信号分隔的支架,通过交叉相互作用分子的局部组装促进和稳定蛋白质-蛋白质相互作用,导致凋亡放大和凋亡信号阈值降低。依地福新还使套细胞淋巴瘤细胞中存活的PI3K/Akt信号从脂筏中移位,导致Akt抑制。因此,膜脂筏可以作为一种支架结构,在其中促凋亡分子与抗凋亡分子可以发生分离。在这篇综述中,我们总结了我们对于脂筏膜结构域蛋白质组成的重组如何调节细胞死亡的观点,因此可以设想它是癌症治疗中的一个新靶点。